News from acelrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015.

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jul 24, 2015, 08:30 ET
AcelRx logo.

AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the...

Jul 02, 2015, 07:00 ET
AcelRx logo

Zalviso™ Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 22, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 14, 2015, 07:00 ET
AcelRx logo.

AcelRx Awarded Contract from Department of Defense to Advance ARX-04

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

May 04, 2015, 16:04 ET
AcelRx logo

AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 01, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May

REDWOOD CITY, Calif., May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development...

Apr 30, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 4th, 2015

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Apr 14, 2015, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Announces Presentation Of Sublingual Sufentanil Data At The Society of American Gastrointestinal and Endoscopic Surgeons Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that a poster presentation will be made at the Annual Society of American...

Mar 20, 2015, 15:00 ET
AcelRx logo.

AcelRx Appoints Howard B. Rosen as Interim CEO

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 16, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Announces Initiation Of Pivotal Phase 3 Trial For ARX-04

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 09, 2015, 16:05 ET
AcelRx logo.

AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 09, 2015, 07:30 ET

AcelRx Provides Regulatory Update on Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 04, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Feb 20, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Feb 04, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Present at BIO CEO & Investor Conference

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Dec 02, 2014, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 20, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate in Four Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 13, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 10, 2014, 16:01 ET
AcelRx logo.

AcelRx Pharmaceuticals Reports Third Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...